OMOP Concept 911979
Daratumumab and hyaluronidase monotherapy
StandardRegimenHemOnc4962Regimen
Maps from
0
Descendants
0
Valid from
31 May 2020
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(24)Roll up to these when you need a wider cohort.
- 1Anti-CD38 antibody-containing regimen
- 1daratumumab
- 1Daratumumab and hyaluronidase-containing regimen
- 1hyaluronidase
- 1Single-agent targeted therapy regimen
- 1Targeted therapy
- 1Targeted therapy-containing regimen
- 2Anti-CD20 antibody
- 2Anti-CD38 antibody
- 2Anti-HER2 antibody
- 2Anti-PD-L1 antibody
- 2Generic class-based regimen
- 2Light-chain (AL) amyloidosis medication
- 2Named class-based regimen
- 2Neutral
- 3Antineoplastic monoclonal antibody
- 3Drugs by local effect
- 3Immunostimulatory monoclonal antibody
- 3Immunosuppressive monoclonal antibody
- 4Antibody medication
- 4Immunosuppressant
- 4Immunotherapeutic
- 4Targeted therapeutic
- 5Antineoplastics by class effect
Get this concept via the API
Resolve Daratumumab and hyaluronidase monotherapy - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/911979?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card